Table 1.

Relationship between CANT1 Expression and Clinicopathological Data of Primary Prostate Carcinoma Specimens (RPE) in Cohort #1

	n = 238 Median (range)/cases (percentage)	Golgi staining			Cytoplasmic staining
Parameter		CANT1 low	CANT1 high	P value	CANT1 low	CANT1 high	P value
Age	65 (50–77)			0.894			0.782
≤64 years		68	46		78	36
>64 years		76	48		82	42
Pre-OP PSA	12.3 (0.2–209)			0.669			0.026⁎
≤10 ng/mL		55	35		51	39
>10 ng/mL		67	49		84	32
Gleason score				0.764			0.823
5–6	37 (15.5%)	21	16		24	13
7	138 (58%)	86	52		95	43
8–10	63 (26.5%)	37	26		41	22
pT status				0.893			0.069
pT2	142 (59.7%)	85	57		102	40
pT3/4	96 (40.3%)	59	37		58	38
Margin status				0.583			0.563
R0	150 (63%)	92	58		100	50
R1	85 (35.7%)	49	36		60	25

Pre-OP PSA, preoperative prostate-specific antigen; RPE, radical prostatectomy.

^⁎Statistically significant.